|
|
|
|
| LEADER |
01150naa a2200289 i 4500 |
| 001 |
NSK01001016951 |
| 003 |
HR-ZaNSK |
| 005 |
20190115153322.0 |
| 007 |
ta |
| 008 |
190110s2016 ci a | |0|| ||eng |
| 035 |
|
|
|a (HR-ZaNSK)001016951
|
| 040 |
|
|
|a HR-ZaNSK
|b hrv
|c HR-ZaNSK
|e ppiak
|
| 042 |
|
|
|a croatica
|
| 044 |
|
|
|a ci
|c hr
|
| 080 |
1 |
|
|a 615
|2 2011
|
| 100 |
1 |
|
|a Hassan, Said A.
|4 aut
|
| 245 |
1 |
0 |
|a Development and validation of HPLC and CE methods for simultaneous determination of amlodipine and atorvastatin in the presence of their acidic degradation products in tablets /
|c Said A. Hassan, Eman S. Elzanfaly, Maissa Y. Salem, Badr A. El-Zeany.
|
| 300 |
|
|
|b Ilustr.
|
| 504 |
|
|
|a Bibliografija: 28 jed.
|
| 653 |
|
0 |
|a Atorvastatin
|a Amlodipin
|a Kapilarna elektroforeza
|a HPLC metoda
|a Lijekovi
|a Kiseline
|a Razgradnja
|
| 700 |
1 |
|
|a Elzanfaly, Eman S.
|4 aut
|
| 700 |
1 |
|
|a Salem, Maissa Y.
|4 aut
|
| 700 |
1 |
|
|a El-Zeiny, Badr
|4 aut
|
| 773 |
0 |
|
|t Acta pharmaceutica (Zagreb)
|x 1330-0075
|g 66 (2016), 4 ; str. 479-490
|w nsk.(HR-ZaNSK)000054908
|
| 981 |
|
|
|b B05/16
|
| 998 |
|
|
|b gtao1901
|
| 856 |
4 |
1 |
|u https://hrcak.srce.hr/161221
|y Elektronička verzija članka
|